Literature DB >> 16440142

The effect of VVI pacing on P-wave dispersion in patients with dual-chamber pacemakers.

Basri Amasyali1, Sedat Köse, Kudret Aytemir, Ilknur Can, Giray Kabakci, Lale Tokgozoglu, Hilmi Ozkutlu, Nasih Nazli, Ersoy Isik, Ali Oto.   

Abstract

The incidence of atrial fibrillation is higher in patients with VVI pacing mode than DDD pacing mode, but the likely mechanism is not clearly understood. We aimed to evaluate whether short-term VVI pacing increases inhomogeneous atrial conduction by using P-wave dispersion. Forty-seven patients (32 men, 15 women, mean age 54 +/- 13 years) with DDD pacemakers were enrolled in this study. Twelve-lead surface ECGs were obtained in all patients during VDD pacing after an observation period of 1 week. The mode was then changed to VVI and 12 lead surface ECGs were obtained after another 1-week observation period. P-wave durations were calculated in all 12 leads in both VDD and VVI pacing modes. The difference between the maximum and the minimum P-wave duration was defined as the P-wave dispersion (PWD = P(max) - P(min)). P-wave maximum duration (P(max)) calculated in VVI pacing mode was significantly longer than in VDD pacing mode (128 +/- 19 vs 113 +/- 16 ms, P < 0.001). There was no significant difference in the P-wave minimum durations (80 +/- 13 ms vs 79 +/- 12 ms, P = 0.7) between VVI pacing and VDD pacing. The P-wave dispersion value was higher in the VVI pacing mode than in the VDD pacing mode (48 +/- 8 ms vs 34 +/- 7 ms, P < 0.001). Short-term VVI pacing induces prolongation of P(max) and results in increased P-wave dispersion, which might be responsible for the development of atrial fibrillation more frequently in these patients than in those with the VDD pacing mode.

Entities:  

Mesh:

Year:  2006        PMID: 16440142     DOI: 10.1007/s00380-005-0851-7

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   1.814


  32 in total

1.  Is DDD pacing superior to VVI,R? A study on cardiac sympathetic nerve activity and myocardial oxygen consumption at rest and during exercise.

Authors:  C Linde-Edelstam; P Hjemdahl; S K Pehrsson; H Aström; R Nordlander
Journal:  Pacing Clin Electrophysiol       Date:  1992-04       Impact factor: 1.976

2.  Electrocardiographic left atrial enlargement. Electrophysiologic, echocardiographic and hemodynamic correlates.

Authors:  M E Josephson; J A Kastor; J Morganroth
Journal:  Am J Cardiol       Date:  1977-06       Impact factor: 2.778

3.  Expression of brain natriuretic peptide gene in human heart. Production in the ventricle.

Authors:  K Hosoda; K Nakao; M Mukoyama; Y Saito; M Jougasaki; G Shirakami; S Suga; Y Ogawa; H Yasue; H Imura
Journal:  Hypertension       Date:  1991-06       Impact factor: 10.190

4.  Selective versus non-selective antiarrhythmic approach for prevention of atrial fibrillation after coronary surgery: is there a need for pre-operative risk stratification? A prospective placebo-controlled study using low-dose sotalol.

Authors:  U K Weber; S Osswald; M Huber; P Buser; K Skarvan; P Stulz; C Schmidhauser; M Pfisterer
Journal:  Eur Heart J       Date:  1998-05       Impact factor: 29.983

Review 5.  Atrial fibrillation and stroke: new ideas, persisting dilemmas.

Authors:  J L Halperin; R G Hart
Journal:  Stroke       Date:  1988-08       Impact factor: 7.914

6.  Plasma brain natriuretic peptide as a biochemical marker for atrioventricular sequence in patients with pacemakers.

Authors:  H Horie; T Tsutamoto; N Ishimoto; K Minai; H Yokohama; M Nozawa; M Izumi; A Takaoka; T Fujita; T Sakamoto; O Kito; H Okamura; M Kinoshita
Journal:  Pacing Clin Electrophysiol       Date:  1999-02       Impact factor: 1.976

7.  P wave dispersion on 12-lead electrocardiography in patients with paroxysmal atrial fibrillation.

Authors:  K Aytemir; N Ozer; E Atalar; E Sade; S Aksöyek; K Ovünç; A Oto; F Ozmen; S Kes
Journal:  Pacing Clin Electrophysiol       Date:  2000-07       Impact factor: 1.976

8.  Factors associated with the development of atrial fibrillation in COPD patients: the role of P-wave dispersion.

Authors:  Tufan Tükek; Pinar Yildiz; Vakur Akkaya; Mehmet Akif Karan; Dursun Atilgan; Veysel Yilmaz; Ferruh Korkut
Journal:  Ann Noninvasive Electrocardiol       Date:  2002-07       Impact factor: 1.468

Review 9.  Physiological pacing: present status and future developments.

Authors:  A Wirtzfeld; G Schmidt; F C Himmler; K Stangl
Journal:  Pacing Clin Electrophysiol       Date:  1987-01       Impact factor: 1.976

10.  Detection of patients with hypertrophic cardiomyopathy at risk for paroxysmal atrial fibrillation during sinus rhythm by P-wave dispersion.

Authors:  Sedat Köse; Kudret Aytemir; Elif Sade; Ilknur Can; Necla Ozer; Basri Amasyali; Serdar Aksöyek; Kenan Ovünç; Ferhan Ozmen; Enver Atalar; Ersoy Işik; Sirri Kes; Ertan Demirtaş; Ali Oto
Journal:  Clin Cardiol       Date:  2003-09       Impact factor: 2.882

View more
  3 in total

1.  Outcome of cardioverter-defibrillator implant in patients with arrhythmogenic right ventricular cardiomyopathy.

Authors:  Giuseppe Boriani; Paolo Artale; Mauro Biffi; Cristian Martignani; Lorenzo Frabetti; Cinzia Valzania; Igor Diemberger; Matteo Ziacchi; Matteo Bertini; Claudio Rapezzi; Mario Parlapiano; Angelo Branzi
Journal:  Heart Vessels       Date:  2007-05-21       Impact factor: 2.037

2.  Minimally invasive video-assisted thoracoscopic left ventricular epicardial lead implantation for biventricular pacing in a patient with persistent left superior vena cava.

Authors:  Yukihiro Matsuno; Yoshio Mori; Yukio Umeda; Matsuhisa Imaizumi; Hiroshi Takiya
Journal:  Heart Vessels       Date:  2008-07-23       Impact factor: 2.037

3.  Right ventricular outflow tract septal pacing is superior to right ventricular apical pacing.

Authors:  Cao Zou; Jianping Song; Hui Li; Xingmei Huang; Yuping Liu; Caiming Zhao; Xin Shi; Xiangjun Yang
Journal:  J Am Heart Assoc       Date:  2015-04-20       Impact factor: 5.501

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.